期刊文献+

哈萨克族心力衰竭患者血浆和肽素、N端前体脑钠肽水平的变化及临床意义 被引量:5

Changes and clinical significance of copeptin and NT-proBNP levels in Kazakhs patients with heart failure
原文传递
导出
摘要 目的:探讨哈萨克族心力衰竭(心衰)患者血浆和肽素(Copeptin)、N端前体脑钠肽(NT-proBNP)水平的变化及临床意义。方法:使用酶联免疫吸附测定法(ELISA)测定90例哈族心衰患者(心衰组)和30例同期住院哈族无心功能不全患者(对照组)的血浆Copeptin、NT-proBNP水平,超声心动图测量左房内径(LAD)、左室舒张末内径(LVEDD)、左室射血分数(LVEF)、左室短轴缩短率(FS)。结果:哈族心衰患者血浆Copeptin、NT-proBNP显著高于对照组,且随NYHA心功能分级的升高而升高,各组间差异具有统计学意义(P<0.01)。心衰患者Copeption、NT-proBNP具有相关性(r=0.692,P<0.01)。单因素分析显示,Copeption、NT-proBNP与LAD、LVEDD呈正相关(均P<0.01),与LVEF、FS呈负相关(均P<0.01)。在心衰组,分别将年龄、性别、NY-HA分级、超声心动图所测LAD、LVEDD、LVEF、EF、FS共8个因素行多元逐步回归分析,结果只有NYHA和LVEF是Copeptin、NT-proBNP的独立相关因素。结论:哈族心衰患者血浆Copeptin、NT-proBNP水平显著升高,并与心衰严重程度有良好的相关性。Copeptin、NT-proBNP可以作为判断哈族心衰患者心功能的一个良好指标。 Objective:To explore the change and significance of copeptin and NT-proBNP in Kazakhs patients with heart failure(HF).Method:The 90 Kazakhs patients with heart failure were analyzed as HF group and 30 patients without heart failure were served as control group.Every subject's plasma copeptin and NT-proBNP were detected by ELISA.The parameters of left atrial diameter(LAD),left ventricle end-diastolic diameter(LVEDD),left ventricle ejection fraction(LVEF),fraction shortening(FS) were detected with echocardiography.Result:The plasma copeptin and NT-proBNP levels of HF group were significantly higher than control group(P0.01).Copeptin and NT-proBNP levels also increased with the classification of NYHA(P0.01).Correlation analysis revealed a strong correlation between copeptin and NT-proBNP(r=0.692,P0.01).The levels of copeptin and NT-proBNP positively correlated with LAD,LVEDD(all P0.01),and was negatively correlated with LVEF,FS(all P0.01).Multivariate stepwise regression analysis including age,gender,NYHA classification,LAD,LVEDD,LVEF and FS revealed that only NYHA classification and LVEF were independent predictors.Conclusion:The concentration of copeptin and NT-proBNP was increased in Kazakhs Patients with heart failure,which are closely associated with NYHA grading of cardiac function.Measuring plasma copeptin and NT-proBNP level may be helpful for judging the severity of heart failure.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2011年第12期925-928,共4页 Journal of Clinical Cardiology
关键词 心力衰竭 和肽素 N端前体脑钠肽 哈萨克族 copeptin NT-proBNP heart failure Kazakhs
  • 相关文献

参考文献12

  • 1GEGENHUBER A, STRUCK J, BERGMANN A, et al. Comparative evaluation of B-type natriuretic pep- tide, mid regional pro-A-type natriuretic peptide, mid-dregional pro-adrenmedullin, and Copeptin to predict 1-year mortality in patients with acute desta- billized heart failure[J]. Card Fail, 2007,13: 42--49.
  • 2HUNT P J, RICHARDS A M, NICHOLLS M G, et al. lmmunoreactive amino-terminal pro-brain natri- uretic peptide (NT-proBNP): a new marker of cardiac impairment[J]. Clin Endocrinol, 1997,47 : 287--296.
  • 3汪芳,李卫,黄洁,王莉,边文彦,庞会敏,王洋,顼志敏,李一石.血浆N末端原脑利钠肽水平对慢性心力衰竭患者长期预后的预测价值[J].中华心血管病杂志,2006,34(1):28-32. 被引量:83
  • 4杨毅宁,马依彤,刘芬,黄定,李晓梅,黄莺,唐琪,陈邦党,马翔,谢翔,杜雷,高霞,王迎洪,古丽娜尔·白托拉,于子翔.新疆汉、维吾尔、哈萨克族慢性心力衰竭流行病学调查及其患病率研究[J].中华心血管病杂志,2010,38(5):460-464. 被引量:48
  • 5陆再英,钟南山,谢毅,等.内科学[M].7版.北京:人民卫生出版社,2006:165-181.
  • 6SCHRIER R W. Water and sodium retention in edem- atous disorders: role of vasopressin and aldosterone[J]. Am J Med,2006,119:S47--53.
  • 7MORGENTHALER N G, STRUCK J, BERGAM ANN A, et al. Assay for the measurement of copep- tin, a stable peptide derived from the precursor of vasopressin[J]. Clin Chen, 2006,52: 112-- 119.
  • 8NEUHOLD S, HUELSMANN M, STRUNK G, et al. Comparison of copeptin, B-type natriuretic peptide and amino-terminal pro-B-type natriuretie peptide in patients with chronic heart failure: prediction of death at different Stages of the disease[J]. J Am Coll Cardi- ol,2008,52:266--272.
  • 9STOISER B, MORTL D, MORGENTHALER N G, et al. Copeptin a fragment of the vasopressin precur- sor, as a novel predictor of outcome in heart failure [J]. Eur J Clin Invest,2006,36:771--778.
  • 10VOORS A A, HAEHLING S V, ANKER S D, et al. C-terminal provasopressin (Copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction., results from the OP- TIMAAL study[J]. Eur Heart J,2009,30:1187-- 1194.

二级参考文献22

  • 1徐新娟,汪师贞.新疆地区高血压流行病学调查研究回顾[J].新疆医科大学学报,2004,27(3):312-314. 被引量:56
  • 2陆再英.心力衰竭.见:叶任高.主编.内科学.第6版.北京:人民卫生出版社,2006.161-166.
  • 3Kannel WB,Ho K,Thorn T.Changing epidemiological features of cardiac failure.Br Heart J,1994,72:S3-S9.
  • 4Kawamura H,Jumabay M,Mitsubayashi H,et al.24-hour,blood pressure in Uygur,Kazakh and Han elderly subjects in China.Hypertens Res,2000,23:177-185.
  • 5American Heart Association.2002 Heart and Stroke Statistical Up data.Dallas,TX:American Heart Association,2002:19.
  • 6Cleland JG,Daubert JC,Erdmann E,et al.The effect of cardiac resynchronization on morbidity and mortality in heart failure.N Engl.J Med,2005,352:1539-1549.
  • 7Januzzi JL Jr, Camargo CA, Anwaruddin S, et al. The N-terminal pro-BNP investigation of dyspnea in the emergency department(PRIDE) study. Am J Cardiol.2005 .95 :948-954.
  • 8Pemberton C J, Yandle TG, Radenmker MT, et al. Amino-terminal proBNP in ovine plasma: evidence for enhanced secretion in response to cardiac overload. Am J Physiol, 1998, 275:1200-1208.
  • 9Mancia G. Neurohumoral activation in congestive heart failure. Am Heart J, 1990,120:1532-1537.
  • 10Yeo KT, Wu AH, Apple FS, et aL Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clin Chim Acta, 2003, 338: 107-115.

共引文献130

同被引文献35

  • 1GONZALEZ A, LOPEZ B, RAVASSA S, et al. Car- diotrophin-1 in hypertensive heart disease[J]. Endo- crine,2012,15 : 230-- 235.
  • 2CELIK A, SAHIN S, KOC F, et al. Cardiotrophin-1 plasma levels are increased in patients with diastolic heart failure[J]. Med Sci Monit, 2012,18 : CR25 -- 31.
  • 3LOPEZ B, GONZALEZ A, LASARTE J J, et al. Is plasma cardiotrophin 1 a maker of hypertensive heart disease[J]. J Hypertens, 2005,23 : 625-- 630.
  • 4TAKAMOTO Y, AOYANM T, IWANAGA Y, el al. Increased expression of cardiotrophin-1 during ventricular remodeling in hypertensive rats[J]. Am J Physiol, 2002,282 : H896 -- 901.
  • 5LOPEZ-ANDReS N, MARTIN-FERNANDEZ B, ROS- SIGNOL P, el al. A role for cardiotrophin-1 in myocardial remodeling induced by aldosterone[J]: Am J Physiol Heart Circ Physiol,2011,301 : H2372--2382.
  • 6ROBADOR P A, MORENO M U, BELOQUI O, et al. Protective effect of the 1742(C/G) polymorphism of human cardiotrophin 1 against left ventricutar hy- pertrophy in essential hypertension[J]. J Hypertens, 2010,28 : 2219 -- 2226.
  • 7JOUGASAKI M, I.ESKINEN H, LARSEN A M, et al. Ventricular cardiotrophin-1 activation precedes BNP in experimental heart failure[J]. Peptides,2003, 24:889--892.
  • 8Morgenthaler NG;Struck J;Bergm ann A.Assay for the measurement of copeptin,a stable peptide derived from the precursor of vasopressin,2006(01).
  • 9Wayne L. Miller,Karen A. Hartman,David O. Hodge,Stacy Hartman,Joachim Struck,Nils G. Morgenthaler,Andreas Bergmann,Allan S. Jaffe.Response of Novel Biomarkers to BNP Infusion in Patients with Decompensated Heart Failure: A Multimarker Paradigm[J]Journal of Cardiovascular Translational Research,2009(4).
  • 10Alfons Gegenhuber,Joachim Struck,Benjamin Dieplinger,Werner Poelz,Richard Pacher,Nils G. Morgenthaler,Andreas Bergmann,Meinhard Haltmayer,Thomas Mueller.Comparative Evaluation of B-Type Natriuretic Peptide, Mid-Regional Pro-A-type Natriuretic Peptide, Mid-Regional Pro-Adrenomedullin, and Copeptin to Predict 1-Year Mortality in Patients With Acute Destabilized Heart Failure[J]Journal of Cardiac Failure,2007(1).

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部